Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.

Richards KA, Shannon I, Treanor JJ, Yang H, Nayak JL, Sant AJ.

J Infect Dis. 2019 Aug 26. pii: jiz433. doi: 10.1093/infdis/jiz433. [Epub ahead of print]

PMID:
31504634
2.

Monoclonal antibody responses after recombinant HA vaccine versus subunit inactivated influenza virus vaccine: a comparative study.

Henry C, Palm AE, Utset HA, Huang M, Ho IY, Zheng NY, Fitzgerald T, Neu KE, Chen YQ, Krammer F, Treanor JJ, Sant AJ, Topham DJ, Wilson PC.

J Virol. 2019 Aug 21. pii: JVI.01150-19. doi: 10.1128/JVI.01150-19. [Epub ahead of print]

PMID:
31434733
3.

Continuous Readout versus Titer-Based Assays of Influenza Vaccine Trials: Sensitivity, Specificity, and False Discovery Rates.

Li D, Wang J, Garigen J, Treanor JJ, Zand MS.

Comput Math Methods Med. 2019 May 8;2019:9287120. doi: 10.1155/2019/9287120. eCollection 2019.

4.

Improved Specificity and False Discovery Rates for Multiplex Analysis of Changes in Strain-Specific Anti-Influenza IgG.

Li D, Wang J, Treanor JJ, Zand MS.

Comput Math Methods Med. 2019 Apr 15;2019:3053869. doi: 10.1155/2019/3053869. eCollection 2019.

5.

Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals.

Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, Holden-Wiltse J, Topham DJ, Treanor JJ, Ertl HC, Schmader KE, Cobey S, Krammer F, Hensley SE, Greenberg H, He XS, Wilson PC.

Cell Host Microbe. 2019 Mar 13;25(3):357-366.e6. doi: 10.1016/j.chom.2019.01.002. Epub 2019 Feb 19.

PMID:
30795982
6.

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus.

Tesini BL, Kanagaiah P, Wang J, Hahn M, Halliley JL, Chaves FA, Nguyen PQT, Nogales A, DeDiego ML, Anderson CS, Ellebedy AH, Strohmeier S, Krammer F, Yang H, Bandyopadhyay S, Ahmed R, Treanor JJ, Martinez-Sobrido L, Golding H, Khurana S, Zand MS, Topham DJ, Sangster MY.

J Virol. 2019 Apr 3;93(8). pii: e00169-19. doi: 10.1128/JVI.00169-19. Print 2019 Apr 15.

PMID:
30728266
7.

Differences in the influenza-specific CD4 T cell immunodominance hierarchy and functional potential between children and young adults.

Shannon I, White CL, Murphy A, Qiu X, Treanor JJ, Nayak JL.

Sci Rep. 2019 Jan 28;9(1):791. doi: 10.1038/s41598-018-37167-5.

8.
9.

Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.

Babu TM, Perera RAPM, Wu JT, Fitzgerald T, Nolan C, Cowling BJ, Krauss S, Treanor JJ, Peiris M.

J Infect Dis. 2018 Aug 24;218(7):1054-1060. doi: 10.1093/infdis/jiy291.

10.

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.

Wang J, Hilchey SP, DeDiego M, Perry S, Hyrien O, Nogales A, Garigen J, Amanat F, Huertas N, Krammer F, Martinez-Sobrido L, Topham DJ, Treanor JJ, Sangster MY, Zand MS.

PLoS One. 2018 Apr 11;13(4):e0193680. doi: 10.1371/journal.pone.0193680. eCollection 2018.

11.

Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial.

Dunkle LM, Izikson R, Patriarca PA, Goldenthal KL, Cox M, Treanor JJ.

Pediatrics. 2018 May;141(5). pii: e20173021. doi: 10.1542/peds.2017-3021. Epub 2018 Apr 2.

12.

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody.

Nogales A, Piepenbrink MS, Wang J, Ortega S, Basu M, Fucile CF, Treanor JJ, Rosenberg AF, Zand MS, Keefer MC, Martinez-Sobrido L, Kobie JJ.

Sci Rep. 2018 Mar 12;8(1):4374. doi: 10.1038/s41598-018-22307-8.

13.

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.

Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Griffin MR, Keipp Talbot H, Treanor JJ, Wentworth DE, Fry AM.

J Infect Dis. 2018 Jun 20;218(2):189-196. doi: 10.1093/infdis/jix634.

14.

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.

Stadlbauer D, Rajabhathor A, Amanat F, Kaplan D, Masud A, Treanor JJ, Izikson R, Cox MM, Nachbagauer R, Krammer F.

mSphere. 2017 Dec 13;2(6). pii: e00502-17. doi: 10.1128/mSphere.00502-17. eCollection 2017 Nov-Dec.

15.

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583. doi: 10.1073/pnas.1712377114. Epub 2017 Nov 6.

16.

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.

Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL.

Clin Vaccine Immunol. 2017 May 5;24(5). pii: e00571-16. doi: 10.1128/CVI.00571-16. Print 2017 May.

17.

Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.

Treanor JJ, Chu L, Essink B, Muse D, El Sahly HM, Izikson R, Goldenthal KL, Patriarca P, Dunkle LM.

Vaccine. 2017 Feb 7;35(6):923-928. doi: 10.1016/j.vaccine.2016.12.053. Epub 2017 Jan 11.

PMID:
28089141
18.

CLINICAL PRACTICE. Influenza Vaccination.

Treanor JJ.

N Engl J Med. 2016 Sep 29;375(13):1261-8. doi: 10.1056/NEJMcp1512870. Review. No abstract available.

PMID:
27682035
19.

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine.

Wright PF, Hoen AG, Ilyushina NA, Brown EP, Ackerman ME, Wieland-Alter W, Connor RI, Jegaskanda S, Rosenberg-Hasson Y, Haynes BC, Luke CJ, Subbarao K, Treanor JJ.

Open Forum Infect Dis. 2016 May 23;3(2):ofw108. doi: 10.1093/ofid/ofw108. eCollection 2016 Apr.

20.

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.

Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, Subbarao K, Palese P, Krammer F, Wilson PC.

Cell Host Microbe. 2016 Jun 8;19(6):800-13. doi: 10.1016/j.chom.2016.05.014.

21.

Genomics reveals historic and contemporary transmission dynamics of a bacterial disease among wildlife and livestock.

Kamath PL, Foster JT, Drees KP, Luikart G, Quance C, Anderson NJ, Clarke PR, Cole EK, Drew ML, Edwards WH, Rhyan JC, Treanor JJ, Wallen RL, White PJ, Robbe-Austerman S, Cross PC.

Nat Commun. 2016 May 11;7:11448. doi: 10.1038/ncomms11448.

22.

Incidence and viral aetiologies of acute respiratory illnesses (ARIs) in the United States: a population-based study.

Szilagyi PG, Blumkin A, Treanor JJ, Gallivan S, Albertin C, Lofthus GK, Schnabel KC, Donahue JG, Thompson MG, Shay DK.

Epidemiol Infect. 2016 Jul;144(10):2077-86. doi: 10.1017/S0950268816000315. Epub 2016 Mar 2.

PMID:
26931351
23.

Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.

DeDiego ML, Anderson CS, Yang H, Holden-Wiltse J, Fitzgerald T, Treanor JJ, Topham DJ.

Immunology. 2016 Jun;148(2):160-73. doi: 10.1111/imm.12594. Epub 2016 Mar 30.

24.

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.

Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, McLean HQ, Fry AM.

Pediatrics. 2016 Feb;137(2):e20153279. doi: 10.1542/peds.2015-3279. Epub 2016 Jan 5.

25.

Prospects for Broadly Protective Influenza Vaccines.

Treanor JJ.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S355-63. doi: 10.1016/j.amepre.2015.09.012. Review.

PMID:
26590435
26.

Maintenance of brucellosis in Yellowstone bison: linking seasonal food resources, host-pathogen interaction, and life-history trade-offs.

Treanor JJ, Geremia C, Ballou MA, Keisler DH, White PJ, Cox JJ, Crowley PH.

Ecol Evol. 2015 Sep;5(17):3783-99. doi: 10.1002/ece3.1633. Epub 2015 Aug 20.

27.

Prospects for broadly protective influenza vaccines.

Treanor JJ.

Vaccine. 2015 Nov 27;33 Suppl 4:D39-45. doi: 10.1016/j.vaccine.2015.08.053. Epub 2015 Sep 1. Review.

PMID:
26338145
28.

Abundance and specificity of influenza reactive circulating memory follicular helper and non-follicular helper CD4 T cells in healthy adults.

Leddon SA, Richards KA, Treanor JJ, Sant AJ.

Immunology. 2015 Sep;146(1):157-62. doi: 10.1111/imm.12491. Epub 2015 Jul 14.

29.

Serological Correlates of Protection against a GII.4 Norovirus.

Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, Vinjé J, Jiang X, Gregoricus N, Frenck RW, Moe CL, Chen WH, Ferreira J, Barrett J, Opekun AR, Estes MK, Borkowski A, Baehner F, Goodwin R, Edmonds A, Mendelman PM.

Clin Vaccine Immunol. 2015 Aug;22(8):923-9. doi: 10.1128/CVI.00196-15. Epub 2015 Jun 3.

30.

A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.

Baz M, Paskel M, Matsuoka Y, Zengel JR, Cheng X, Treanor JJ, Jin H, Subbarao K.

J Virol. 2015 Jul;89(13):6907-17. doi: 10.1128/JVI.00280-15. Epub 2015 Apr 22.

31.

Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.

Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ.

Open Forum Infect Dis. 2015 Jan 3;2(1):ofu115. doi: 10.1093/ofid/ofu115. eCollection 2015 Jan.

32.

High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine.

Halliley JL, Khurana S, Krammer F, Fitzgerald T, Coyle EM, Chung KY, Baker SF, Yang H, Martínez-Sobrido L, Treanor JJ, Subbarao K, Golding H, Topham DJ, Sangster MY.

J Infect Dis. 2015 Oct 15;212(8):1270-8. doi: 10.1093/infdis/jiv210. Epub 2015 Apr 2.

33.

Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans.

Watson JM, Francis JN, Mesens S, Faiman GA, Makin J, Patriarca P, Treanor JJ, Georges B, Bunce CJ.

Virol J. 2015 Feb 3;12:13. doi: 10.1186/s12985-015-0240-5.

34.

Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza.

Richards KA, Nayak J, Chaves FA, DiPiazza A, Knowlden ZA, Alam S, Treanor JJ, Sant AJ.

J Infect Dis. 2015 Jul 1;212(1):86-94. doi: 10.1093/infdis/jiu662. Epub 2014 Dec 9.

35.

Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility.

Rzasa RM, Frohn MJ, Andrews KL, Chmait S, Chen N, Clarine JG, Davis C, Eastwood HA, Horne DB, Hu E, Jones AD, Kaller MR, Kunz RK, Miller S, Monenschein H, Nguyen T, Pickrell AJ, Porter A, Reichelt A, Zhao X, Treanor JJS, Allen JR.

Bioorg Med Chem. 2014 Dec 1;22(23):6570-6585. doi: 10.1016/j.bmc.2014.10.013.

PMID:
25456383
36.

Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.

Sundararajan A, Sangster MY, Frey S, Atmar RL, Chen WH, Ferreira J, Bargatze R, Mendelman PM, Treanor JJ, Topham DJ.

Vaccine. 2015 Jan 15;33(4):568-76. doi: 10.1016/j.vaccine.2014.09.073. Epub 2014 Nov 22.

37.

A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.

Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Treanor JJ, Jin H, Subbarao K.

J Virol. 2015 Feb;89(3):1652-9. doi: 10.1128/JVI.02449-14. Epub 2014 Nov 19.

38.

Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.

Nayak JL, Richards KA, Yang H, Treanor JJ, Sant AJ.

J Infect Dis. 2015 May 1;211(9):1408-17. doi: 10.1093/infdis/jiu616. Epub 2014 Nov 6.

39.

Expanding the options for confronting pandemic influenza.

Treanor JJ.

JAMA. 2014 Oct 8;312(14):1401-2. doi: 10.1001/jama.2014.12558. No abstract available.

PMID:
25291574
40.

Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.

Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW Jr, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM.

J Infect Dis. 2015 Mar 15;211(6):870-8. doi: 10.1093/infdis/jiu497. Epub 2014 Sep 9.

41.

Live attenuated and inactivated influenza vaccines in children.

Ilyushina NA, Haynes BC, Hoen AG, Khalenkov AM, Housman ML, Brown EP, Ackerman ME, Treanor JJ, Luke CJ, Subbarao K, Wright PF.

J Infect Dis. 2015 Feb 1;211(3):352-60. doi: 10.1093/infdis/jiu458. Epub 2014 Aug 26.

42.

Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody.

Kobie JJ, Treanor JJ, Ritchlin CT.

Immunol Invest. 2014;43(6):606-15. doi: 10.3109/08820139.2013.871555.

43.

A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.

Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM.

J Infect Dis. 2014 Dec 1;210(11):1763-71. doi: 10.1093/infdis/jiu337. Epub 2014 Jun 20.

PMID:
24951828
44.

Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus.

O'Donnell CD, Wright A, Vogel L, Boonnak K, Treanor JJ, Subbarao K.

Clin Vaccine Immunol. 2014 May;21(5):737-46. doi: 10.1128/CVI.00790-13. Epub 2014 Mar 19.

45.

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, García-Sastre A, Palese P.

J Virol. 2014 Apr;88(8):3976-85. doi: 10.1128/JVI.03095-13. Epub 2014 Jan 22.

46.

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.

Treanor JJ, Essink B, Hull S, Reed S, Izikson R, Patriarca P, Goldenthal KL, Kohberger R, Dunkle LM.

Vaccine. 2013 Nov 19;31(48):5760-5. doi: 10.1016/j.vaccine.2013.08.064. Epub 2013 Sep 27.

PMID:
24075920
47.

Gain-of-function experiments on H7N9.

Fouchier RA, Kawaoka Y, Cardona C, Compans RW, García-Sastre A, Govorkova EA, Guan Y, Herfst S, Orenstein WA, Peiris JS, Perez DR, Richt JA, Russell C, Schultz-Cherry SL, Smith DJ, Steel J, Tompkins SM, Topham DJ, Treanor JJ, Tripp RA, Webby RJ, Webster RG.

Science. 2013 Aug 9;341(6146):612-3. doi: 10.1126/science.341.6146.612. No abstract available.

PMID:
23929965
48.

Avian flu: Gain-of-function experiments on H7N9.

Fouchier RA, Kawaoka Y, Cardona C, Compans RW, Fouchier RA, García-Sastre A, Govorkova EA, Guan Y, Herfst S, Kawaoka Y, Orenstein WA, Peiris JS, Perez DR, Richt JA, Russell C, Schultz-Cherry SL, Smith DJ, Steel J, Tompkins SM, Topham DJ, Treanor JJ, Tripp RA, Webby RJ, Webster RG.

Nature. 2013 Aug 8;500(7461):150-1. doi: 10.1038/500150a. No abstract available.

PMID:
23925229
49.

Bovine brucellosis in wildlife: using adaptive management to improve understanding, technology and suppression.

White PJ, Treanor JJ, Geremia C, Wallen RL, Blanton DW, Hallac DE.

Rev Sci Tech. 2013 Apr;32(1):263-70.

50.

Supplemental Content

Loading ...
Support Center